ÂÜÀòÂÒÂ×

Stephen Dukacz is a seasoned professional in medical affairs with extensive experience in the pharmaceutical industry, currently serving as the Director of Global Medical Affairs for Rare Disease and Gene Therapy at Pfizer since May 2023. Previously, Stephen held key roles at Ipsen, including Medical Affairs Team Leader for Neuroscience, Endocrinology, and Rare Diseases, where significant contributions included launching comprehensive medical plans for multiple brands. Stephen's career at Pfizer spans over 18 years, during which vital responsibilities included regional medical director roles in both Emerging Asia and Latin America, focusing on establishing patient-centric medical affairs capabilities. Stephen's academic credentials include a Ph.D. in Cardiovascular, Renal Physiology, and an MSc in Health Economics, Policy, and Management, complemented by various certifications in leadership and medical affairs. Currently, Stephen also advises on the Pharmaceutical & Healthcare Management and Innovation Program at Queen's University.